ES71
TEAS SECTION 71 RECEIVED
13/07/2026
Voltar para busca
Dado oficial do USPTO
AB AB BIOTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
13/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
14/12/2018
Data de registro
14/01/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/01/2020
Última transação
13/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
85
Localização do titular
ES
Examinador
CHANG, ELIZABETH YI HSUAN
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a circle enclosing the stylized lowercase initials "ab" with an arrow attached to the top of the vertical bar in the letter "B," and the stylized wording "AB BIOTICS" to the right of the design.
Titulares e representantes
Titulares
AB-BIOTICS, S. A.
Representantes
Justin R. Young DTL Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productspharmaceutical preparations for treating diseases and conditions related to cardiometabolic healthgastrointestinal healthoral healthimmune healthdermatological healthurogenital healthmental health and microbiota dysbiosis; preparations for medical and veterinary usemedical and veterinary preparations for treating diseases and conditions related to cardiometabolic healthgastrointestinal healthoral healthimmune healthdermatological healthurogenital healthmental health and microbiota dysbiosis; hygiene and sanitary products for medical use namelydisinfectant tabletsstickscapsulesgelscreamssoaps and lotions; dietetic foods and beverages adapted for medical or veterinary use; food for babies; food supplements for humans or animals; bacterial preparations for medical or veterinary use; bacteriological preparations for pharmaceutical use; biotechnological preparations for medical use; bacteriological culture media; cultures of microorganisms for medical use; cultures of microorganisms for veterinary use; probiotic bacterial formulations in the nature of preparations for medical use; probiotic bacterial formulas in the nature of preparations for veterinary use; nutraceutical preparations for medical or therapeutic use to treat diseases and conditions related to cardiometabolic healthgastrointestinal healthoral healthimmune healthdermatological healthurogenital healthmental health and microbiota dysbiosis; dietary and nutritional supplements; probiotic supplements; nutraceutical products as dietary supplements
Classe 35
Assistance in the conduct of business or commercial functions of a commercial or industrial company; wholesale and retail store services and online wholesale and retail store services provided via global communication networks featuring food supplements and pharmaceuticalmedicalveterinarydieteticprobiotic and nutraceutical products and preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/01/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/04/2020
FIMP
FINAL DISPOSITION PROCESSED
23/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
14/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
22/11/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/10/2019
PUBO
PUBLISHED FOR OPPOSITION
29/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/10/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2019
ALIE
ASSIGNED TO LIE
23/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
19/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
19/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2019
RFNT
REFUSAL PROCESSED BY IB
12/04/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/03/2019
RFRR
REFUSAL PROCESSED BY MPU
22/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/03/2019
CNRT
NON-FINAL ACTION WRITTEN
12/03/2019
DOCK
ASSIGNED TO EXAMINER
12/03/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AB AB BIOTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.